Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buagafuran in Generalized Anxiety Disorder
NCT06243640Phase 3Recruiting
- Sponsor
- Beijing Union Pharmaceutical Factory
- Start
- Jul 2023
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of buagafuran in generalized anxiety disorder (GAD), sponsored by Beijing Union Pharmaceutical Factory. Started Jul 2023; status: recruiting.
02
Drugs
buagafuran
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT06243640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06243640.